These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17276763)

  • 1. Haemoglobin concentrations in chronic kidney disease.
    Fernandes M; Sawa H; Bellini G
    Lancet; 2007 Feb; 369(9559):365. PubMed ID: 17276763
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
    Phrommintikul A; Haas SJ; Elsik M; Krum H
    Lancet; 2007 Feb; 369(9559):381-8. PubMed ID: 17276778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemoglobin targets: we were wrong, time to move on.
    Strippoli GF; Tognoni G; Navaneethan SD; Nicolucci A; Craig JC
    Lancet; 2007 Feb; 369(9559):346-50. PubMed ID: 17276756
    [No Abstract]   [Full Text] [Related]  

  • 5. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
    Fernández-Gallego J; Gutiérrez C
    Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
    [No Abstract]   [Full Text] [Related]  

  • 6. Anemia management in patients with chronic renal insufficiency.
    Kausz AT; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2000 Dec; 36(6 Suppl 3):S39-51. PubMed ID: 11118157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
    Schaefer RM; Schaefer L; Heidland A
    Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
    [No Abstract]   [Full Text] [Related]  

  • 9. Target haemoglobin concentrations in chronic kidney disease.
    Reinhold SW; Krämer BK; Banas B
    Lancet; 2007 May; 369(9572):1517. PubMed ID: 17482980
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European best practice guidelines 17-18: adverse effects.
    Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Carveth BG; Thompson K
    Nephrol Dial Transplant; 2000; 15 Suppl 4():51-6. PubMed ID: 11052149
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of erythropoietin in predialysis patients.
    Anderson S
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin.
    Beresford CH
    N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
    [No Abstract]   [Full Text] [Related]  

  • 14. Target haemoglobin concentrations in chronic kidney disease.
    Nonoguchi H; Nakayama Y; Inoue T; Kohda Y; Tomita K
    Lancet; 2007 May; 369(9572):1517. PubMed ID: 17482981
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1991 Feb; 135(5):163-6. PubMed ID: 2002863
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic target for the use of erythropoietin (EPO): is subnormal better than normal?].
    Karle H; Hansen NE
    Ugeskr Laeger; 2007 May; 169(19):1782-3. PubMed ID: 17537352
    [No Abstract]   [Full Text] [Related]  

  • 17. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP; Benz RL; Sigler MH; Brown JM
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
    Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.